OTC Markets OTCQX - Delayed Quote USD
Orgenesis Inc. (ORGS)
2.4900
+0.2800
+(12.67%)
At close: April 23 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 30,000 | 1 |
| Sales | 30,000 | 1 |
| Net Shares Purchased (Sold) | 0 | 2 |
| Total Insider Shares Held | 1.04M | -- |
| % Net Shares Purchased (Sold) | 0.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SAFIER JACOB Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.51 - 0.59 per share. | Indirect | 16,883 | Jun 24, 2024 |
| SAFIER JACOB Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.50 - 0.58 per share. | Indirect | 16,259 | Jun 24, 2024 |
| MILLER VICTOR Chief Financial Officer | Conversion of Exercise of derivative security at price 0.50 per share. | Direct | 12,500 | Apr 1, 2024 |
| SAFIER JACOB Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.33 per share. | Indirect | 3,332 | Feb 1, 2024 |
| SAFIER JACOB Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.29 - 0.93 per share. | Indirect | 213,280 | Jan 31, 2024 |
| CAPLAN VERED Chief Executive Officer | Conversion of Exercise of derivative security at price 0.01 per share. | Direct | 3,338 | Jan 28, 2022 |
| SIDRANSKY DAVID Director | Purchase at price 5.42 - 6.98 per share. | Indirect | 1,072 | May 20, 2020 |
| ADLER YARON Director | -- | Indirect | -- | Jun 11, 2018 |
| BULTOT HUGUES Director | Conversion of Exercise of derivative security at price 356549.04 per share. | Direct | 874,526,014,409 | Nov 17, 2017 |
| UNIVERSITE LIBRE DE BRUXELLES Shareholder | Sale at price 1.83 per share. | Direct | 1,120,662 | Nov 17, 2017 |
| BELENGER OLIVIER Shareholder | Sale at price 0.25 per share. | Indirect | 1,250,000 | Oct 11, 2017 |
| THEODORUS SCA Shareholder | Sale at price 0.25 per share. | Indirect | 1,250,000 | Oct 11, 2017 |
| THEODORUS II SA Shareholder | Sale at price 0.25 per share. | Indirect | 1,250,000 | Oct 11, 2017 |
| CUISON GILBERT ADRIAS President | Sale at price 0.01 per share. | Direct | 1,936 | Jun 28, 2011 |
| GOLEZ JEROME PERALTA Officer and Treasurer | Sale at price 0.01 per share. | Direct | 1,923 | Jun 28, 2011 |
Related Tickers
PYPD PolyPid Ltd.
2.7500
+0.36%
ISCO International Stem Cell Corporation
0.1100
0.00%
CYCCP Cyclacel Pharmaceuticals, Inc.
5.0000
+1.42%
ANEB Anebulo Pharmaceuticals, Inc.
0.9700
0.00%
BVAXF BioVaxys Technology Corp.
0.0286
-0.69%
XTLB XTL Biopharmaceuticals Ltd.
1.2150
-7.25%
DYAI Dyadic International, Inc.
1.2100
-2.42%
ARMP Armata Pharmaceuticals, Inc.
1.3200
+1.08%
OGEN Oragenics, Inc.
0.1940
+3.74%
PMCB PharmaCyte Biotech, Inc.
1.1900
+2.59%